perfluorohexyloctane (Miebo) Report issue

Small molecule Approved FDA

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CCCCCCCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
  • InChIKey: WRYIIOKOQSICTB-UHFFFAOYSA-N
  • Mol. Mass: 432.26
  • ALogP: 7.48
  • ChEMBL Molecule:
    perfluorohexyloctane  
More Chemistry

Pharmacology

  • Mechanisms of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Topical
  • Pro Drug: No

Drug Pricing (per unit)

Australia

$16.6690
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Organizations (4)

Research & Development (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (1)


 

Dry Eye Syndromes (approved 2023)

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Dry Eye Syndromes (Phase 4)

Eye Diseases (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial Organizations: 3

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue